Open Access<p>Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review</p>
Author(s) -
Krzysztof Maria Wilczyński,
Ida Zasada,
Andrzej Siwiec,
Małgorzata Janas–Kozik
Publication year - 2019
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s207580
Subject(s) - neurotypical , autism spectrum disorder , vasopressin , autism , medicine , oxytocin , neuropeptide , population , inclusion and exclusion criteria , clinical psychology , psychiatry , alternative medicine , pathology , environmental health , receptor
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social interactions, communication, and the presence of stereotyped, repetitive behaviors. Oxytocin (OXT) and arginine-vasopressin are neuropeptides produced in hypothalamus and they are related to processing emotions and social behavior. In the light of a growing number of scientific reports related to this issue, the two neurohormones started to be linked with the basis of neurodevelopmental disorders, including the ASD. The aim of this study was a systematic review of previous studies regarding the differences in OXT and vasopressin levels in ASD and neurotypical persons.